Kodiak Sciences
(NASDAQ) KOD
Kodiak Sciences Financials at a Glance
Market Cap
$2.32BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$230.66M
EPS (TTM)
-$4.17
P/E Ratio
-8.87
Dividend
$0.00
Beta (Volatility)
2.31 (High)
Dividend
$0.00
Beta (Volatility)
2.31 (High)
Price
$35.97
Volume
831
Open
$37.81
Price
$35.97
Volume
831
Open
$37.81
Previous Close
$37.02
Daily Range
$35.85 - $37.94
52-Week Range
$3.73 - $47.84
Estimated Earnings Date
Aug 12, 2026
Dividend
$0.00
Beta (Volatility)
2.31 (High)
Price
$35.97
Volume
831
Open
$37.81
Previous Close
$37.02
Daily Range
$35.85 - $37.94
52-Week Range
$3.73 - $47.84
Estimated Earnings Date
Aug 12, 2026
KOD News
KOD: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Kodiak Sciences
Industry
Biotechnology
Sector
Health CareEmployees
124
CEO
Victor Perlroth, MD, MBA
Website
www.kodiak.comHeadquarters
Palo Alto, CA 94304, US
KOD Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-253.85%
Return on Capital
-74.04%
Return on Assets
-75.38%
Earnings Yield
-11.27%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.32BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
62.58M
Volume
831
Avg. Volume
764.70K
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$235.09M
EBITDA
-$201.03M
Operating Cash Flow
-$146.94M
Capital Expenditure
-$1.18M
Free Cash Flow
-$148.12M
Cash & ST Invst.
$169.53M
Total Debt
$155.99M
Kodiak Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$2.32BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$21.25M
N/A
Employees
109
N/A
Net Income
-$58.16M
-1.2%
EBITDA
-$51.82M
-2.1%
Quarterly Fundamentals
Total Cash
$169.53M
+22.1%
Total Debt
$155.99M
+130.6%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$144.33M
+154.6%
Short Term Debt
$11.66M
+6.5%
Return on Assets
-75.38%
N/A
Return on Invested Capital
-91.68%
N/A
Free Cash Flow
-$40.95M
-39.5%
Operating Cash Flow
-$40.01M
-37.6%